ITCI — INTRA-CELLULAR THERAPIES INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 1 SEC-registered investment managers reported holding ITCI (INTRA-CELLULAR THERAPIES INC) in their latest 13F filings, with a combined reported value of $2.54K across 1 shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +0.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Major shareholders of INTRA-CELLULAR THERAPIES INC (ITCI) include Vanguard Group, BlackRock Inc, Pentwater Capital Management LP, ranked by reported 13F value among the 643 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | $2.54K | +0.0% |
| Q1 2026 | 1 | 1 | $2.54K | +0.0% |
| Q4 2025 | 1 | 1 | $2.54K | +0.0% |
| Q3 2025 | 1 | 1 | $2.54K | +0.0% |
| Q2 2025 | 3 | 52.80K | $4.15M | -0.9% |
| Q1 2025 | 392 | 100.97M | $13.30B | -19.5% |
| Q4 2024 | 381 | 99.32M | $8.24B | -1.4% |
| Q3 2024 | 339 | 98.91M | $7.16B | -0.8% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q3 2024 → Q2 2026); the largest single-quarter swing was Q1 2025 (-19.5%).
Top Institutional Holders (Q2 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $2.54K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q1 2026 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $2.54K | 0.00% | Hold |
Q4 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $2.54K | 0.00% | Hold |
Q3 2025 — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1 | $2.54K | 0.00% | Hold |
Q2 2025 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 52.00K | $4.09M | 0.01% | Hold | |
| 797 | $60.15K | 0.00% | Reduce | |
| 1 | $2.54K | 0.00% | Reduce |
Q1 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.52M | $1.26B | 0.02% | Reduce | |
| 8.75M | $1.15B | 0.03% | Add | |
| 5.19M | $684.66M | 13.42% | New | |
| 4.38M | $578.47M | 9.46% | New | |
| 3.58M | $472.22M | 0.07% | Add | |
| 3.49M | $459.75M | 6.92% | New | |
| 3.09M | $407.78M | 9.91% | Add | |
| 3.06M | $403.02M | 1.93% | New | |
| 3.06M | $403.02M | 2.25% | New | |
| 2.66M | $351.21M | 0.02% | Reduce | |
| 2.26M | $297.86M | 1.17% | Add | |
| 2.00M | $263.84M | 8.54% | Hold | |
| 1.83M | $241.74M | 0.02% | Add | |
| 1.82M | $239.47M | 0.05% | Add | |
| 1.78M | $234.99M | 0.01% | Reduce | |
| 1.64M | $216.35M | 6.77% | New | |
| 1.47M | $194.42M | 0.10% | Add | |
| 1.40M | $185.14M | 0.01% | Add | |
| 1.09M | $144.29M | 0.53% | New | |
| 1.06M | $139.56M | 10.45% | New | |
| 931.33K | $122.86M | 0.36% | Add | |
| 923.81K | $121.87M | 0.33% | Add | |
| 923.81K | $121.87M | 0.12% | Add | |
| 895.66K | $118.16M | 0.02% | Reduce | |
| 895.66K | $118.16M | 0.02% | Reduce |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | 1 | 1 | 1 | 1 | 244 | 432 | 486 | 429 | 508 | 486 | 575 | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | — | — | 9.52M | 9.72M | 9.63M | 9.61M | 9.23M | 9.09M | 8.54M | 8.50M | 8.44M | 8.32M | 8.12M | 8.08M | 7.79M | 6.88M | 6.89M |
| BlackRock Inc | — | — | — | — | — | 8.75M | 6.11M | 6.22M | — | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | — | 2.66M | 11.08M | 11.12M | 11.24M | 11.19M | 11.46M | 10.98M | 11.18M | 11.94M | 12.03M | 10.27M | 10.33M | 10.95M | 10.96M | 11.08M |
| Pentwater Capital Management LP | — | — | — | — | — | 5.19M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HBK INVESTMENTS L P | — | — | — | — | — | 4.38M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Norges Bank Investment Management | — | — | — | — | — | 3.58M | 3.21M | 3.20M | 1.94M | 1.54M | 1.20M | 820.42K | — | — | 1.04M | — | — | — | — | — |
| Davidson Kempner Capital Management | — | — | — | — | — | 3.49M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | 759.99K | 5.13M | 5.29M | 3.44M | 1.76M | 2.07M | 2.06M | 1.98M | 1.71M | 1.50M | 187.78K | 189.22K | 157.14K | 140.69K | 142.00K |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM | — | — | — | — | — | 3.09M | 20.28K | 17.34K | — | — | — | — | — | — | — | — | — | — | — | — |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | — | — | — | — | — | 3.06M | — | — | — | 231.00K | — | — | — | — | — | — | — | — | — | — |
| Balyasny Asset Management | — | — | — | — | — | 2.26M | 139.66K | — | 406.71K | 410.63K | 50.00K | — | 130.61K | 7.33K | 668 | 5.31K | — | 31.97K | — | — |
| WASATCH ADVISORS LP | — | — | — | — | — | — | 3.25M | 3.85M | 3.72M | 3.85M | 3.63M | 3.80M | — | — | — | — | — | — | — | — |
| Deep Track Capital, LP | — | — | — | — | — | 2.00M | 2.00M | 1.60M | 1.54M | 175.40K | 2.00M | 2.60M | — | — | — | — | — | — | — | — |
| Invesco Ltd | — | — | — | — | — | 85.07K | 3.08M | 2.99M | 2.94M | 2.07M | 1.96M | 1.94M | 1.97M | 1.82M | 1.78M | 1.68M | 816.19K | 478.38K | 32.44K | 34.20K |
| Avoro Capital Advisors LLC | — | — | — | — | — | 625.00K | 3.05M | 3.05M | 3.00M | 2.48M | 2.26M | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | — | — | — | — | — | 1.83M | 1.72M | 1.71M | 1.69M | 2.07M | 2.00M | 1.91M | 1.84M | 1.75M | 1.67M | 1.62M | 1.59M | 1.47M | 1.29M | 1.27M |
| Bank of America Corp | — | — | — | — | — | 1.82M | 364.37K | 422.51K | 547.72K | 75.00K | 483.29K | 397.67K | 555.12K | 281.13K | 176.41K | 172.19K | 185.74K | 188.56K | 120.45K | 82.80K |
| STATE STREET CORP | — | — | — | — | — | 1.78M | 1.87M | 1.86M | 1.80M | 2.24M | 2.22M | 2.14M | — | — | — | — | — | — | — | — |
| Bellevue Group AG | — | — | — | — | — | — | 2.44M | 2.49M | 2.47M | 2.82M | 3.07M | 3.17M | — | — | — | — | — | — | — | — |
FAQ
Which funds hold ITCI?
As of 2026-Q2, 1 institutional funds reported holding ITCI (INTRA-CELLULAR THERAPIES INC) in SEC 13F filings, with a combined reported value of $2.54K.
How many shares of ITCI do institutions own?
13F filers reported 1 shares of ITCI, worth $2.54K in aggregate at the end of 2026-Q2.
Is institutional ownership of ITCI rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of ITCI?
The largest 13F holders are Vanguard Group, BlackRock Inc, Pentwater Capital Management LP, HBK INVESTMENTS L P, Norges Bank Investment Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of INTRA-CELLULAR THERAPIES INC?
The major shareholders of INTRA-CELLULAR THERAPIES INC (ITCI) by reported 13F value are Vanguard Group, BlackRock Inc, Pentwater Capital Management LP, HBK INVESTMENTS L P, Norges Bank Investment Management, among 643 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.